A/S BI BIOMEDICAL VENTURE ANNEX KOMPLEMENTAR: Financial statements 2015
CVR: 27908047
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
A/S BI BIOMEDICAL VENTURE ANNEX KOMPLEMENTAR (CVR 27908047) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK -28,000 and a net result of DKK 700,000 compared with DKK 104,000 the year before. Equity in the 2015 report amounted to DKK 3,046,000. The solvency ratio was 94.1%.
- Gross Profit
- DKK -28,000
- Profit/Loss
- DKK 700,000
- Equity
- DKK 3,046,000
- Total Assets
- DKK 3,237,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | -28K | 700K | 3M | - |
| 2014 | - | -16K | 104K | 2.3M | - |
| 2013 | - | -16K | -196K | 2.2M | - |
| 2012 | - | -34K | 490K | 2.4M | - |
Official annual report
How creditworthy is A/S BI BIOMEDICAL VENTURE ANNEX KOMPLEMENTAR?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
A/S BI BIOMEDICAL VENTURE ANNEX KOMPLEMENTAR has published its annual report for 2014. Gross profit came to DKK -16,000, and the net result was DKK 104,000.
About A/S BI BIOMEDICAL VENTURE ANNEX KOMPLEMENTAR
A/S BI BIOMEDICAL VENTURE ANNEX KOMPLEMENTAR is a Danish company of the type Aktieselskab based in København K, founded in 2004. The company is registered under the industry Anden finansiel formidling i.a.n.. The management consists of Ahmet Turan Kayhan. The board consists of Andrea Panzieri (chair), Allan Funk Nissen and Ahmet Turan Kayhan. The company is owned by BI HOLDING A/S. According to the 2023 annual report, the company had an average of 0 employees. In 2025, the company reported a net result of DKK -3,000 compared with DKK 2,000 the year before. Equity in the 2025 report amounted to DKK 2,482,000.
